About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

MNCs

Company: Post Graduate Institute of Medical Education and Research, Chandigarh
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: 2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details

Recruiting NCT NCT06629324

Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy From Brain Hypoxia

Not yet reported Vinmec Research Institute of Stem Cell and Gene Technology 58 participants Est. completion 2027-01-31 2 sites

Other conditions: Autism Spectrum Disorder
View official trial listing →
Recruiting NCT NCT06896344

Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells

Fondazione IRCCS Policlinico San Matteo di Pavia 10 participants Est. completion 2025-08 1 site

Other conditions: Primary Myelofibrosis
View official trial listing →
Completed NCT NCT00300053

ACT34-CMI -- Adult Autologous CD34+ Cells

Not yet reported Lisata Therapeutics, Inc. 321 participants Est. completion 2009-03 26 sites Stand-alone

Other conditions: Myocardial Ischemia
View official trial listing →
Completed NCT NCT00384982

Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study

Not yet reported Medical University of Vienna 116 participants Est. completion 2008-08 1 site Stand-alone

Cardiovascular disease
View official trial listing →
Completed NCT NCT00824005

Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study)

Not yet reported The University of Texas Health Science Center, Houston 92 participants Est. completion 2012-05 5 sites Stand-alone

Other conditions: Chronic Ischemic Heart Disease, Left Ventricular Dysfunction, Angina, Ischemic Cardiomyopathy
View official trial listing →
Completed NCT NCT00955669

Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer

Not yet reported Third Military Medical University 40 participants Est. completion 2010-08 1 site

Other conditions: Autologous Transplantation, Diabetic Foot
View official trial listing →
Status unknown NCT NCT01143168

Stem Cell Therapy for Type 1 Diabetes Mellitus

Not yet reported Cellonis Biotechnology Co. Ltd. 24 participants Est. completion 2011-12 1 site

Other conditions: Type 1 Diabetes Mellitus
View official trial listing →
Status unknown NCT NCT01209611

Autologous Bone Marrow-Derived Mononuclear Cell Transplantation in Accelerating Tissue Expansion and Skin Regeneration

Not yet reported, Not yet reported Shanghai Jiao Tong University School of Medicine 30 participants Est. completion 2014-12 1 site Stand-alone

Other conditions: Tissue Expansion;, Skin Regeneration;, Reconstruction;, Bone Marrow Mononuclear Cells
View official trial listing →
Completed NCT NCT01333982

Neonatal Sepsis, Evaluation, Bangladesh

Not yet reported International Centre for Diarrhoeal Disease Research, Bangladesh 20000 participants Est. completion 2013-12 1 site Stand-alone

Other conditions: Sepsis
View official trial listing →
Completed NCT NCT01343511

Safety and Efficacy of Stem Cell Therapy in Patients With Autism

Not yet reported, Not yet reported Shenzhen Beike Bio-Technology Co., Ltd. 37 participants Est. completion 2011-05 1 site Stand-alone

Other conditions: Autism
View official trial listing →
Status unknown NCT NCT01832441

Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus.

Not yet reported, Not yet reported Chaitanya Hospital, Pune 100 participants Est. completion 2016-09 1 site

Other conditions: Diabetes Mellitus.
View official trial listing →
Status unknown NCT NCT01832454

Safety and Efficacy of Bone Marrow MNC for the Treatment of Cerebral Palsy in Subjects Below 15 Years

Not yet reported, Not yet reported Chaitanya Hospital, Pune 100 participants Est. completion 2015-12 1 site

Other conditions: Cerebral Palsy
View official trial listing →
Status unknown NCT NCT01833975

Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury

Not yet reported, Not yet reported Chaitanya Hospital, Pune 50 participants Est. completion 2016-09 1 site

Other conditions: Spinal Cord Injury.
View official trial listing →
Status unknown NCT NCT01834040

Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy

Not yet reported, Not yet reported Chaitanya Hospital, Pune 30 participants Est. completion 2016-10 1 site

Other conditions: Muscular Dystrophy, Duchenne Muscular Dystrophy
View official trial listing →
Status unknown NCT NCT01834053

Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.

Not yet reported, Not yet reported Chaitanya Hospital, Pune 50 participants Est. completion 2016-06 1 site

Other conditions: Huntington Disease
View official trial listing →
Status unknown NCT NCT01834066

Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.

Not yet reported, Not yet reported Chaitanya Hospital, Pune 25 participants Est. completion 2016-12 1 site

Other conditions: Muscular Dystrophy, Duchenne Muscular Dystrophy,
View official trial listing →
Status unknown NCT NCT01834079

Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease

Not yet reported, Not yet reported Chaitanya Hospital, Pune 24 participants Est. completion 2016-07 1 site

Other conditions: Optic Atrophy
View official trial listing →
Status unknown NCT NCT01834664

Safety and Efficacy of Bone Marrow Derived Autologous Cells Treatment of Cerebral Palsy in Subjects Above 15 Years

Not yet reported, Not yet reported Chaitanya Hospital, Pune 100 participants Est. completion 2016-06 1 site

Other conditions: Ataxic Infantile Cerebral Palsy
View official trial listing →
Status unknown NCT NCT01836562

A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism

Not yet reported, Not yet reported Chaitanya Hospital, Pune 100 participants Est. completion 2016-06 1 site

Other conditions: Autism
View official trial listing →
Status unknown NCT NCT01883661

Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)

Not yet reported, Not yet reported Chaitanya Hospital, Pune 15 participants Est. completion 2016-12 1 site

Other conditions: Multiple Sclerosis
View official trial listing →
Completed NCT NCT02253160

An Evaluation of the Spectra Optia CMNC Collection Procedure

Not yet reported Terumo BCT 23 participants Est. completion 2015-01 2 sites

Other conditions: Healthy Apheresis Donors, Mononuclear (MNC) Cell Donors
View official trial listing →
Completed NCT NCT02280135

Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa

Not yet reported Red de Terapia Celular 8 participants Est. completion 2017-03 1 site Stand-alone

Obstructive sleep apnea
View official trial listing →
Terminated NCT NCT02323477

Human Umbilical Cord Stroma MSC in Myocardial Infarction

Not yet reported, Not yet reported Ankara University 46 participants Est. completion 2018-12-30 1 site

Other conditions: Chronic Ischemic Cardiomyopathy, Coronary Artery Bypass Surgery
View official trial listing →
Completed NCT NCT02387749

Effect Of Mesenchymal Stem Cells Transfusion on the Diabetic Peripheral Neuropathy Patients .

Not yet reported Cairo University 10 participants Est. completion 2016-12 Stand-alone

Other conditions: Diabetic Peripheral Neuropathy
View official trial listing →
Completed NCT NCT02490163

Comparison of Two Automated Mononuclear Collection Systems in Patients Undergoing Extracorporeal Photochemotherapy. A Cross-over Equivalence Study. (MNC_CMNC)

Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 51 participants Est. completion 2016-01 1 site Stand-alone

Other conditions: GvHD, Lung Graft Dysfunction
View official trial listing →
Completed NCT NCT02533895

Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood

Not yet reported Activartis Biotech 67 participants Est. completion 2015-10 2 sites Stand-alone

Other conditions: Childhood Solid Tumor
View official trial listing →
Status unknown NCT NCT02587806

A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

Not yet reported, Not yet reported Novo Cellular Medicine Institute LLP 69 participants Est. completion 2017-02 2 sites Stand-alone

Other conditions: Multiple Sclerosis, Relapsing-Remitting
View official trial listing →
Status unknown NCT NCT02648516

Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected Patients

Not yet reported, Not yet reported Beijing 302 Hospital 20 participants Est. completion 2022-12 1 site Stand-alone

Other conditions: Human Immunodeficiency Virus, Disorder of Immune Reconstitution
View official trial listing →
Completed NCT NCT02651376

Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients

Not yet reported, Not yet reported Beijing 302 Hospital 20 participants Est. completion 2017-08 Stand-alone

Other conditions: Human Immunodeficiency Virus, Immunodeficiency
View official trial listing →
Completed NCT NCT02662400

Assessment of Insulin Sensitivity and β Cell Function by Clamps Studies

Not yet reported, Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 7 participants Est. completion 2016-12 Stand-alone

Other conditions: Diabetes Mellitus, Non-Insulin-Dependent
View official trial listing →
Terminated NCT NCT03111238

The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM

Not yet reported Ixaka Ltd 3 participants Est. completion 2021-03-31 15 sites Stand-alone

Type 2 diabetesCardiovascular disease Other conditions: Peripheral Arterial Disease (PAD), Diabetes Mellitus (DM), Diabetes Mellitus, Type 1, Critical Limb Ischemia (CLI)
View official trial listing →
Terminated NCT NCT03174522

The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM

Not yet reported Ixaka Ltd 49 participants Est. completion 2023-02-13 15 sites Stand-alone

Type 2 diabetesCardiovascular disease Other conditions: Peripheral Arterial Disease (PAD), Diabetes Mellitus (DM), Diabetes Mellitus, Type 1, Critical Limb Ischemia (CLI)
View official trial listing →
Active, not recruiting NCT NCT03880656

BM-MNCs for Lower Extremity Compartment Syndrome Injury

Not yet reported Oregon Health and Science University 18 participants Est. completion 2026-06 1 site Stand-alone

Other conditions: Compartment Syndrome Traumatic Lower Extremity
View official trial listing →
Status unknown NCT NCT03943940

BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients

Not yet reported, Not yet reported Van Hanh General Hospital 60 participants Est. completion 2020-08-30 1 site Stand-alone

Type 2 diabetes
View official trial listing →
Completed NCT NCT04255004

Autologous Peripheral Blood Mononuclear Cells in Diabetic Foot Patients With No-option Critical Limb Ischemia

Not yet reported Ospedale San Donato 76 participants Est. completion 2019-12

Other conditions: Critical Limb Ischemia, Diabetic Foot
View official trial listing →
Status unknown NCT NCT04501341

BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients

Not yet reported, Not yet reported Indonesia University 15 participants Est. completion 2021-12-01 1 site Stand-alone

Type 2 diabetes
View official trial listing →
Status unknown NCT NCT04882683

Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis

Not yet reported Shandong Qilu Stem Cells Engineering Co., Ltd. 50 participants Est. completion 2022-12-31 1 site Stand-alone

Other conditions: Ulcerative Colitis
View official trial listing →
Active, not recruiting NCT NCT04898543

QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors

Not yet reported ImmunityBio, Inc. 50 participants Est. completion 2026-05-31 2 sites Stand-alone

Other conditions: Metastatic Solid Tumor
View official trial listing →
Completed NCT NCT04975698

HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

Not yet reported Catherine Bollard 12 participants Est. completion 2026-01-05 11 sites

Other conditions: HIV Associated Lymphoma
View official trial listing →
Status unknown NCT NCT04997590

Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Traumatic Fracture Healing

Not yet reported Qianfoshan Hospital 40 participants Est. completion 2022-12-10 1 site Stand-alone

Other conditions: Bone Nonunion
View official trial listing →
Completed NCT NCT05000593

Clinical Study of Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Knee Osteoarthritis

Not yet reported Lili Cao 30 participants Est. completion 2022-09-01 1 site Stand-alone

Osteoarthritis
View official trial listing →
Completed NCT NCT05134168

LIFT With or Without Injection of BM-MNCs

Not yet reported Mansoura University 70 participants Est. completion 2021-11-01 1 site

Other conditions: Anal Fistula
View official trial listing →
Completed NCT NCT05193877

Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis:Baghdad 2022

Not yet reported Global Stem Cell Center, Baghdad 60 participants Est. completion 2024-01-16 1 site

Other conditions: Treatment Complication
View official trial listing →
Completed NCT NCT05307536

Autologous BMMNCs Combined With Educational Intervention for ASD

Not yet reported Vinmec Research Institute of Stem Cell and Gene Technology 54 participants Est. completion 2023-12-30 1 site Stand-alone

Other conditions: Autism Spectrum Disorder
View official trial listing →
Status unknown NCT NCT05628272

MNCs for Bone Marrow Failure After Malignant Diseases Children Chemotherapy

Not yet reported Qianfoshan Hospital 20 participants Est. completion 2024-09-01 1 site

Other conditions: Cord
View official trial listing →
Status unknown NCT NCT05999656

Human Cord Blood Mononuclear Cells in the Treatment of Refractory Diabetic Foot

Not yet reported The First Affiliated Hospital with Nanjing Medical University 24 participants Est. completion 2024-11-28 1 site Stand-alone

Other conditions: Refractory Diabetic Foot, Human Cord Blood-derived Mononuclear Cells, Efficacy, Safety, Local Injection
View official trial listing →
Status unknown NCT NCT06427642

Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases

Not yet reported Shandong Qilu Stem Cells Engineering Co., Ltd. 120 participants Est. completion 2025-04-30 1 site Stand-alone

Other conditions: Hypoxic-Ischemic Encephalopathy, Bronchopulmonary Dysplasia, Short Bowel Syndrome
View official trial listing →
Not yet recruiting NCT NCT06729320

A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia

Not yet reported Beijing GoBroad Hospital 40 participants Est. completion 2025-12-01 1 site Stand-alone

Other conditions: Refractory Immune Effector Cell-related Hemocytopenia
View official trial listing →
Not yet recruiting NCT NCT07175207

Study on Safety and Efficacy of UCB-MNCs for Chronic Radiation Enteritis

Not yet reported Zhejiang Cancer Hospital 10 participants Est. completion 2026-12-31 1 site Stand-alone

Other conditions: Chronic Radiation Induced Intestinal Injury, Chronic Radiation Enteritis
View official trial listing →
Not yet recruiting NCT NCT07177456

Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung Injury

Not yet reported Zhejiang Cancer Hospital 10 participants Est. completion 2026-12-31 Stand-alone

Other conditions: Radiation-induced Lung Injury
View official trial listing →
Not yet recruiting NCT NCT07698080

Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

Not yet reported Hematology department of the 920th hospital 60 participants Est. completion 2028-07-03 Stand-alone

Other conditions: Leukemia, Lymphoma, Thalassemia, Aplastic Anemia, Myelodysplastic Syndromes
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT02662400

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.